Reflection Biotechnologies (ReflectionBio) is a patient-driven biotech company focused on developing #GeneTherapy for rare retinal diseases.

Patients are global
Joined March 2018
We are proud to partner with @Invisionbcd in the BY PATIENTS, FOR PATIENTS ™ campaign for #BiettiCrystallineDystrophy (BCD). BCD is a rare blinding disease. It is often misdiagnosed as #RetinitisPigmentosa (RP) or Stargardt Disease. youtu.be/eFogU2bfxcw
1
Are you an RP patient? Do you have crystals in the retina? If so, you may have Bietti’s Crystalline Dystrophy (BCD). BCD is an autosomal recessive #RetinitisPigmentosa (RP) caused by mutations in the CYP4V2 gene. Potential treatments are being developed for BCD. @Invisionbcd
1
1
4
Diva on bietti's crystalline dystrophy (BCD). BCD is a blinding disease. Patients have yellow-white crystals in the retina. It is caused by mutations in the CYP4V2 gene. Currently, BCD is untreatable. ReflectionBio is developing BCD gene therapy. youtu.be/FS4jCA5S2DU
1
3
Thank you, Laurel, for sharing your experience living with #BiettiCrystallineDystrophy (BCD), a rare blinding disease. As a patient-driven biotech company, we are proud to hear that our efforts in developing #BCD #GeneTherapy bring hope to the patient community.
2
businesswire.com/news/home/2… Our Founder’s story: I am a rare disease patient. In the process of turning blind and searching for a cure, I founded ReflectionBio to drive orphan drug R&D. Today, our “By Patients, For Patients” approach achieved a milestone.
1